Fred Grover discusses emerging research on psychedelics, neuroplasticity, and brain health, including healthy aging and integration.

Sophia Ellowen explores common psilocybin misconceptions and why preparation, support, and integration matter beyond the psychedelic experience.

Explore triggers, IFS parts work, psychedelic coaching, ayahuasca integration, and ethical healing practices with Dr. Kathy Gruver.

What happens when psychedelic therapy gets approved? Kimberly Chew explains FDA rules, costs, insurance, safety and access.

Discover how AI is transforming psychedelic integration by helping practitioners provide personalized support between sessions without replacing care.

John Gilchrist of Therapsil explains how psilocybin therapy is helping end-of-life patients ease anxiety, find meaning, and embrace acceptance.

Christian Rasmussen explains what people get wrong about Amanita muscaria, its reported effects, and key safety considerations.

Considering psychedelic work? Learn key safety guidelines, red flags to watch for, and how preparation and integration support lasting change.

Explore iboga and ibogaine through their African roots, safety protocols, addiction research, and the deeply introspective experiences they can inspire.